Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)
- Status
- COMPLETED
- Phase
- PHASE3
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)
- Status
- TERMINATED
- Phase
- PHASE4
Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)
- Status
- TERMINATED
- Phase
- PHASE4
Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)
- Status
- TERMINATED
- Phase
- PHASE2
Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
V930 First in Man (FIM) Study (V930-002)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004)
- Status
- TERMINATED
- Phase
- PHASE2
Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285
- Status
- WITHDRAWN
- Phase
- PHASE3
Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Participants (VICTOR-E1) (MK-7690-020/P03672)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Effectiveness of an Investigational Drug in Elderly Subjects With Low Vitamin D Levels (0822A-009)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
- Status
- TERMINATED
- Phase
- PHASE2
Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)
- Status
- COMPLETED
- Phase
- PHASE3